JP2017522288A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017522288A5 JP2017522288A5 JP2016573587A JP2016573587A JP2017522288A5 JP 2017522288 A5 JP2017522288 A5 JP 2017522288A5 JP 2016573587 A JP2016573587 A JP 2016573587A JP 2016573587 A JP2016573587 A JP 2016573587A JP 2017522288 A5 JP2017522288 A5 JP 2017522288A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- bmdsc
- use according
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010051909 Endometrial atrophy Diseases 0.000 claims description 9
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims description 8
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 8
- 210000000685 uterine artery Anatomy 0.000 claims description 7
- 238000002617 apheresis Methods 0.000 claims description 5
- 210000001185 bone marrow Anatomy 0.000 claims description 5
- 210000005259 peripheral blood Anatomy 0.000 claims description 5
- 239000011886 peripheral blood Substances 0.000 claims description 5
- 210000002565 arteriole Anatomy 0.000 claims description 4
- 230000032692 embryo implantation Effects 0.000 claims description 4
- 230000001483 mobilizing effect Effects 0.000 claims description 4
- 230000003054 hormonal effect Effects 0.000 claims description 3
- 210000000130 stem cell Anatomy 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims 14
- 208000028685 Asherman syndrome Diseases 0.000 claims 2
- 208000002777 Gynatresia Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 description 19
- 230000002357 endometrial effect Effects 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 238000011069 regeneration method Methods 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 3
- 230000003836 peripheral circulation Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462013121P | 2014-06-17 | 2014-06-17 | |
| US62/013,121 | 2014-06-17 | ||
| PCT/IB2015/001715 WO2015193737A1 (en) | 2014-06-17 | 2015-06-05 | Stem cell therapy in endometrial pathologies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020102340A Division JP2020138984A (ja) | 2014-06-17 | 2020-06-12 | 子宮内膜病変における幹細胞治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017522288A JP2017522288A (ja) | 2017-08-10 |
| JP2017522288A5 true JP2017522288A5 (enExample) | 2018-07-12 |
| JP6920062B2 JP6920062B2 (ja) | 2021-08-18 |
Family
ID=54329860
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016573587A Active JP6920062B2 (ja) | 2014-06-17 | 2015-06-05 | 子宮内膜病変における幹細胞治療 |
| JP2020102340A Pending JP2020138984A (ja) | 2014-06-17 | 2020-06-12 | 子宮内膜病変における幹細胞治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020102340A Pending JP2020138984A (ja) | 2014-06-17 | 2020-06-12 | 子宮内膜病変における幹細胞治療 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US11129851B2 (enExample) |
| EP (3) | EP4012023B1 (enExample) |
| JP (2) | JP6920062B2 (enExample) |
| CN (2) | CN116747241A (enExample) |
| AU (1) | AU2015275798B2 (enExample) |
| BR (1) | BR112016029558A2 (enExample) |
| CA (1) | CA2952559C (enExample) |
| CY (2) | CY1122615T1 (enExample) |
| DK (2) | DK3158057T3 (enExample) |
| ES (3) | ES2983444T3 (enExample) |
| HR (3) | HRP20191240T1 (enExample) |
| HU (3) | HUE058328T2 (enExample) |
| LT (2) | LT3569697T (enExample) |
| MX (1) | MX377300B (enExample) |
| PL (3) | PL3569697T3 (enExample) |
| PT (2) | PT3569697T (enExample) |
| RS (3) | RS65719B1 (enExample) |
| RU (1) | RU2725006C2 (enExample) |
| SI (2) | SI3569697T1 (enExample) |
| SM (3) | SMT202400270T1 (enExample) |
| TR (1) | TR201910410T4 (enExample) |
| WO (1) | WO2015193737A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
| EP3467124A1 (en) | 2012-06-06 | 2019-04-10 | Fundació Institut de Recerca Biomèdica IRB (Barcelona) | Method for the diagnosis, prognosis and treatment of lung cancer metastasis |
| CA2888122A1 (en) | 2012-10-12 | 2014-04-17 | Inbiomotion S.L. | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis using c-maf |
| US10119171B2 (en) | 2012-10-12 | 2018-11-06 | Inbiomotion S.L. | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis |
| KR20150122786A (ko) | 2013-03-15 | 2015-11-02 | 펀다시오 인스티튜트 드 르세르카 바이오메디카 (아이알비 바르셀로나) | 암 전이의 진단, 예후 및 치료를 위한 방법 |
| BR112016029558A2 (pt) | 2014-06-17 | 2017-08-22 | Igenomix S L | terapia de células-tronco em patologias endometriais |
| AU2017281631B2 (en) * | 2016-06-23 | 2023-06-15 | Tithon Biotech, Inc. | Cells expressing parathyroid hormone 1 receptor and uses thereof |
| RU2699029C1 (ru) * | 2018-12-10 | 2019-09-03 | Частное образовательное учреждение дополнительного профессионального образования "Академия медицинского образования имени Федора Ивановича Иноземцева" (ЧОУ ДПО "Академия медицинского образования им. Ф.И. Иноземцева") | Способ использования мезенхимальных стволовых клеток для улучшения состояния рубца на матке |
| RU2741621C1 (ru) * | 2020-09-25 | 2021-01-28 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации | Способ лечения внутриматочных синехий |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5240922A (en) | 1989-05-05 | 1993-08-31 | Northern Sydney Area Health Service | Fertility enhancement |
| US6979533B2 (en) | 1992-06-12 | 2005-12-27 | The Trustees Of The University Of Pennsylvania | Determination of endometrial receptivity toward embryo implantation |
| CA2203718A1 (en) | 1997-04-25 | 1998-10-25 | University Of British Columbia | Cadherin-11 as an indicator of viable pregnancy |
| IL127896A0 (en) | 1998-12-31 | 1999-10-28 | Gail Laster | A novel treatment for preeclampsia and related diseases |
| AU2001240096A1 (en) | 2000-03-08 | 2001-09-17 | Rebecca L. Dubowy | Methods of diagnosing and monitoring endometrial glandular development |
| JP2004504275A (ja) | 2000-05-24 | 2004-02-12 | シエーリング アクチエンゲゼルシャフト | フィブリン−１の医薬用途 |
| US6780594B2 (en) | 2000-09-25 | 2004-08-24 | Schering Aktiengesellschaft | Method for in vitro diagnosis of endometriosis |
| AUPR673001A0 (en) | 2001-07-31 | 2001-08-23 | Prince Henry's Institute Of Medical Research | Pregnancy-related enzyme activity |
| DE10139874A1 (de) | 2001-08-10 | 2003-04-30 | Schering Ag | Humane Mater-Proteine |
| GB0201284D0 (en) | 2002-01-21 | 2002-03-06 | Isis Innovation | Screening methods for contraceptive and fertility agents |
| US20030186300A1 (en) | 2002-03-20 | 2003-10-02 | Ali Akoum | Methods and products for modulation of reproductive processes and for diagnosis, prognostication and treatment of related conditions |
| EP1511863A4 (en) | 2002-05-14 | 2006-12-27 | Univ Leland Stanford Junior | ENDOMETRIAL GENES FOR THE DETECTION OF ENDOMETRIAL DISORDERS |
| DE10236405A1 (de) | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
| ATE338763T1 (de) | 2002-08-02 | 2006-09-15 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie |
| DE10361928A1 (de) | 2002-12-21 | 2004-07-01 | Universität Leipzig | Verfahren und Mittel zur Bestimmung von bestimmten Zuständen bzw. Veränderungen im Uterusepithel und im Epithel anderer Organe |
| EP1660228A1 (en) | 2003-08-21 | 2006-05-31 | PamGene B.V. | Microarray support for bioprobe synthesis |
| EP1670902A4 (en) | 2003-09-08 | 2008-05-07 | Univ Texas | METHOD AND COMPOSITION FOR ENHANCING i IN VITRO /i EMBRYO DEVELOPMENT BY SUPPLEMENTING CULTURE MEDIUM WITH PROSTAGLANDIN OR A PROSTAGLANDIN ANALOG |
| JP2007504807A (ja) | 2003-09-08 | 2007-03-08 | ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム | 培養培地にプロスタグランジン又はプロスタグランジン類似物を補足することによってインビトロ胚発生を高めるための方法及び組成 |
| DE602004028513D1 (de) | 2003-12-23 | 2010-09-16 | Mount Sinai Hospital Corp | Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern |
| JP2008501035A (ja) | 2004-05-28 | 2008-01-17 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | 妊孕性関連障害の治療におけるｉｌ−１７の使用 |
| US20090111140A1 (en) * | 2006-03-31 | 2009-04-30 | Koninklijke Philips Electronics N.V. | Systems and methods for cell measurement utilizing ultrashort t2* |
| JP2007278750A (ja) | 2006-04-04 | 2007-10-25 | Ono Pharmaceut Co Ltd | プロスタグランジン類及びその類縁体の定量方法 |
| US20120269774A1 (en) * | 2006-09-21 | 2012-10-25 | Medistem Laboratories, Inc | Allogeneic stem cell transplants in non-conditioned recipients |
| GB0703683D0 (en) * | 2007-02-26 | 2007-04-04 | Ark Therapeutics Ltd | The treatment of complications in pregnancy |
| US9259233B2 (en) * | 2007-04-06 | 2016-02-16 | Hologic, Inc. | Method and device for distending a gynecological cavity |
| US8673850B2 (en) | 2008-05-30 | 2014-03-18 | Institut De Recherches Cliniques De Montreal | PCSK9 inhibitors and methods of use thereof |
| WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
| WO2013166281A1 (en) * | 2012-05-02 | 2013-11-07 | Cedars-Sinai Medical Center | Bi-functional compositions for targeting cells to diseased tissues and methods of using same |
| EP2348318A1 (en) | 2010-01-21 | 2011-07-27 | Equipo Ivi Investigación, S.L. | Diagnostic method for endometrial receptivity |
| PT2768976T (pt) | 2011-10-21 | 2018-04-05 | Inst Nat Sante Rech Med | Métodos para avaliar a receptividade endométrica de uma paciente após hiperestimulação ovárica controlada |
| US9423402B2 (en) | 2011-11-30 | 2016-08-23 | Singapore Health Services Pte. Ltd. | GM1 ganglioside to annexin V microparticle polypeptide ratio for biological monitoring |
| SG11201407667UA (en) | 2012-06-27 | 2015-02-27 | Hoffmann La Roche | MEANS AND METHODS APPLYING sFlt-1/PlGF OR ENDOGLIN/PlGF RATIO TO RULE-OUT ONSET OF PREECLAMPSIA WITHIN A CERTAIN TIME PERIOD |
| RU2515475C1 (ru) | 2012-11-15 | 2014-05-10 | Федеральное государственное бюджетное учреждение науки ИНСТИТУТ ЦИТОЛОГИИ РОССИЙСКОЙ АКАДЕМИИ НАУК | Способ стимуляции образования децидуальной оболочки эндометрия в эксперименте |
| CA2943284A1 (en) | 2014-03-21 | 2015-11-05 | Igenomix S.L. | Early detection of preeclampsia |
| BR112016029558A2 (pt) | 2014-06-17 | 2017-08-22 | Igenomix S L | terapia de células-tronco em patologias endometriais |
-
2015
- 2015-06-05 BR BR112016029558A patent/BR112016029558A2/pt not_active Application Discontinuation
- 2015-06-05 WO PCT/IB2015/001715 patent/WO2015193737A1/en not_active Ceased
- 2015-06-05 TR TR2019/10410T patent/TR201910410T4/tr unknown
- 2015-06-05 CN CN202310575540.1A patent/CN116747241A/zh active Pending
- 2015-06-05 AU AU2015275798A patent/AU2015275798B2/en active Active
- 2015-06-05 EP EP22150013.5A patent/EP4012023B1/en active Active
- 2015-06-05 HR HRP20191240 patent/HRP20191240T1/hr unknown
- 2015-06-05 PL PL19169309T patent/PL3569697T3/pl unknown
- 2015-06-05 HR HRP20220419TT patent/HRP20220419T1/hr unknown
- 2015-06-05 RU RU2017101147A patent/RU2725006C2/ru active
- 2015-06-05 RS RS20240690A patent/RS65719B1/sr unknown
- 2015-06-05 JP JP2016573587A patent/JP6920062B2/ja active Active
- 2015-06-05 SM SM20240270T patent/SMT202400270T1/it unknown
- 2015-06-05 DK DK15781411.2T patent/DK3158057T3/da active
- 2015-06-05 HR HRP20240798TT patent/HRP20240798T1/hr unknown
- 2015-06-05 US US15/318,825 patent/US11129851B2/en active Active
- 2015-06-05 ES ES22150013T patent/ES2983444T3/es active Active
- 2015-06-05 PT PT191693092T patent/PT3569697T/pt unknown
- 2015-06-05 MX MX2016016756A patent/MX377300B/es active IP Right Grant
- 2015-06-05 PL PL15781411T patent/PL3158057T3/pl unknown
- 2015-06-05 RS RSP20190913 patent/RS59210B1/sr unknown
- 2015-06-05 LT LTEP19169309.2T patent/LT3569697T/lt unknown
- 2015-06-05 SM SM20190400T patent/SMT201900400T1/it unknown
- 2015-06-05 HU HUE19169309A patent/HUE058328T2/hu unknown
- 2015-06-05 PL PL22150013.5T patent/PL4012023T3/pl unknown
- 2015-06-05 LT LTEP15781411.2T patent/LT3158057T/lt unknown
- 2015-06-05 EP EP19169309.2A patent/EP3569697B8/en active Active
- 2015-06-05 PT PT15781411T patent/PT3158057T/pt unknown
- 2015-06-05 HU HUE22150013A patent/HUE067463T2/hu unknown
- 2015-06-05 SI SI201531822T patent/SI3569697T1/sl unknown
- 2015-06-05 ES ES15781411T patent/ES2736117T3/es active Active
- 2015-06-05 CN CN201580043147.1A patent/CN107073040A/zh active Pending
- 2015-06-05 DK DK19169309.2T patent/DK3569697T3/da active
- 2015-06-05 ES ES19169309T patent/ES2910306T3/es active Active
- 2015-06-05 RS RS20220339A patent/RS63093B1/sr unknown
- 2015-06-05 HU HUE15781411 patent/HUE044823T2/hu unknown
- 2015-06-05 SM SM20220155T patent/SMT202200155T1/it unknown
- 2015-06-05 CA CA2952559A patent/CA2952559C/en active Active
- 2015-06-05 EP EP15781411.2A patent/EP3158057B1/en active Active
- 2015-06-05 SI SI201530822T patent/SI3158057T1/sl unknown
-
2019
- 2019-07-16 CY CY20191100753T patent/CY1122615T1/el unknown
-
2020
- 2020-06-12 JP JP2020102340A patent/JP2020138984A/ja active Pending
-
2022
- 2022-04-05 CY CY20221100258T patent/CY1125938T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015131795A5 (enExample) | ||
| MX2025008493A (es) | Agentes de union a fibroblastos y uso de estos | |
| RU2017101147A (ru) | Терапия стволовыми клетками при патологиях эндометрия | |
| EA201991692A1 (ru) | Иммуносконструированные плюрипотентные клетки | |
| PH12021552887A1 (en) | Modified viral particles and uses thereof | |
| Singhal et al. | Endothelial cell fitness dictates the source of regenerating liver vasculature | |
| MX339469B (es) | Agentes inductores de apotosis para el tratamiento de cancer y enfermedades inmunes y autoinmunes. | |
| MX2013004817A (es) | Enfermedad inflamatoria. | |
| RU2018110647A (ru) | Арильные, гетероарильные и гетероциклические соединения для лечения заболеваний | |
| CR20120347A (es) | Agentes inductores de apoptosis para el tratamiento de cáncer y enfermedades inmunes y autoinmunes | |
| Galipeau | Mesenchymal stromal cells for graft-versus-host disease: a trilogy | |
| EA201891931A1 (ru) | Новые ингибиторы фосфатидилинозитол-3-киназы гамма | |
| MY178445A (en) | Novel antibody binding to tfpi and composition comprising the same | |
| JP2017105861A5 (enExample) | ||
| JP2016509050A5 (enExample) | ||
| JP2017507145A5 (enExample) | ||
| Kim et al. | Pharmacoeconomic impact of up-front use of plerixafor for autologous stem cell mobilization in patients with multiple myeloma | |
| WO2016066722A3 (en) | Bacteriophage combinations for human or animal therapy | |
| WO2019055776A3 (en) | Compositions and methods for treatment of diseases involving cxcl1 function | |
| CN111770924A (zh) | 用于治疗乳腺癌的雌激素受体降解剂 | |
| King et al. | Bone marrow stem cell therapy for liver disease | |
| JP2018509479A5 (enExample) | ||
| Rodriguez | Interferon-α | |
| WO2014143763A3 (en) | Angiogenic compositions for wounds, articular joints and graft materials | |
| HK40080669A (en) | Pharmaceutical composition for the treatment of pulmonary vascular disease and/or cardiac dysfunction in fontan-palliated patients |